Over the past decade, great strides have been made in identifying gene aberrations and deregulated pathways that are associated with specific disease states. These association studies guide experimental studies aimed at identifying the aberrant genes and networks that cause the disease states. This requires functional manipulation of these genes and networks in laboratory models of normal and diseased cells. One approach is to assess molecular and biological responses to high-throughput RNA interference (RNAi)-induced gene knockdown. These responses can be revealed by immunofluorescent staining for a molecular or cellular process of interest and quantified using fluorescence image analysis. These applications are typically performed in multiwell format, but are limited by high reagent costs and long plate processing times. These limitations can be mitigated by analyzing cells grown in cell spot microarray (CSMA) format. CSMAs are produced by growing cells on small (~200 mm diameter) spots with each spot carrying an siRNA with transfection reagent. The spacing between spots is only a few hundred micrometers, thus thousands of cell spots can be arranged on a single cell culture surface. These high-density cell cultures can be immunofluorescently stained with minimal reagent consumption and analyzed quickly using automated fluorescence microscopy platforms. This review covers basic aspects of imaging-based CSMA technology, describes a wide range of immunofluorescence assays that have already been implemented successfully for CSMA screening and suggests future directions for advanced RNAi screening experiments.
References
[1]
Ziauddin, J.; Sabatini, D.M. Microarrays of cells expressing defined cDNAs. Nature 2001, 411, 107–110, doi:10.1038/35075114.
Snijder, B.; Sacher, R.; R？m？, P.; Liberali, P.; Mench, K.; Wolfrum, N.; Burleigh, L.; Scott, C.C.; Verheije, M.H.; Mercer, J.; et al. Single-cell analysis of population context advances RNAi screening at multiple levels. Mol. Syst. Biol. 2012, 8, doi:10.1038/msb.2012.9.
[5]
Hutchins, J.R.; Toyoda, Y.; Hegemann, B.; Poser, I.; Hériché, J.K.; Sykora, M.M.; Augsburg, M.; Hudecz, O.; Buschhorn, B.A.; Bulkescher, J.; et al. Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science 2010, 328, 593–599, doi:10.1126/science.1181348.
[6]
Rantala, J.K.; M？kel？, R.; Aaltola, A.R.; Laasola, P.; Mpindi, J.P.; Nees, M.; Saviranta, P.; Kallioniemi, O. A cell spot microarray method for production of high density siRNA transfection microarrays. BMC Genom. 2011, 28, doi:10.1186/1471-2164-12-162.
[7]
Cekaite, L.; Rantala, J.K.; Bruun, J.; Guriby, M.; Agesen, T.H.; Danielsen, S.A.; Lind, G.E.; Nesbakken, A.; Kallioniemi, O.; Lothe, R.A.; Skotheim, R.I. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 2012, 14, 868–879.
[8]
Neumann, B.; Walter, T.; Hériché, J.K.; Bulkescher, J.; Erfle, H.; Conrad, C.; Rogers, P.; Poser, I.; Held, M.; Liebel, U.; et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010, 464, 721–727, doi:10.1038/nature08869.
[9]
Doil, C.; Mailand, N.; Bekker-Jensen, S.; Menard, P.; Larsen, D.H.; Pepperkok, R.; Ellenberg, J.; Panier, S.; Durocher, D.; Bartek, J.; et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 2009, 136, 435–446, doi:10.1016/j.cell.2008.12.041.
[10]
Rantala, J.K.; Pouwels, J.; Pellinen, T.; Laasola, P.; Potter, C.; Sundberg, J.P.; Kallioniemi, O.; Parsons, M.; Salmi, M.; Ivaska, J. Sharpin is an endogenous inhibitor of β1-integrin activation. Nat. Cell Biol. 2011, 13, 1315–1324, doi:10.1038/ncb2340.
[11]
Pellinen, T.; Rantala, J.K.; Arjonen, A.; Mpindi, J.P.; Kallioniemi, O.; Ivaska, J. A functional genomic analysis of β1-integrin activity regulators. J. Cell Sci. 2012, 125, 649–661, doi:10.1242/jcs.090704.
[12]
Winograd-Katz, S.E.; Itzkovitz, S.; Kam, Z.; Geiger, B. Multiparametric analysis of focal adhesion formation by RNAi-mediated gene knockdown. J. Cell Biol. 2009, 186, 423–436, doi:10.1083/jcb.200901105.
[13]
Bailey, S.N.; Ali, S.M.; Carpenter, A.E.; Higgins, C.O.; Sabatini, D.M. Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat. Methods 2006, 3, 117–122.
[14]
Moffat, J.; Grueneberg, D.A.; Yang, X.; Kim, S.Y.; Kloepfer, A.M.; Hinkle, G.; Piqani, B.; Eisenhaure, T.M.; Luo, B.; Grenier, J.K.; et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124, 1283–1298, doi:10.1016/j.cell.2006.01.040.
[15]
McGowan, E.M.; Alling, N.; Jackson, E.A.; Yagoub, D.; Haass, N.K.; Allen, J.D.; Martinello-Wilks, R. Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay. PLoS One 2011, 6, e20623, doi:10.1371/journal.pone.0020623.
[16]
Bj？rkman, M.; ？stling, P.; H？rm？, V.; Virtanen, J.; Mpindi, J.P.; Rantala, J.; Mirtti, T.; Vesterinen, T.; Lundin, M.; Sankila, A.; et al. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene 2012, 31, 3444–3456.
[17]
Rantala, J.K.; Edgren, H.; Lehtinen, L.; Wolf, M.; Kleivi, K.; Vollan, H.K.; Aaltola, A.R.; Laasola, P.; Kilpinen, S.; Saviranta, P.; et al. Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2. Neoplasia 2010, 12, 877–888.
[18]
Stellaris？ Probe Designer. Available online: http://www.biosearchtech.com/stellarisdesigner (accessed on 15 February 2013).
[19]
Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646–674, doi:10.1016/j.cell.2011.02.013.
[20]
Cancer Genome Atlas (TCGA). Available online: http://cancergenome.nih.gov/ (accessed on 15 February 2013).
[21]
Strauss, R.; Li, Z.Y.; Liu, Y.; Beyer, I.; Persson, J.; Sova, P.; M？ller, T.; Pesonen, S.; Hemminki, A.; Hamerlik, P.; et al. Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 2011, 6, e16186, doi:10.1371/ journal.pone.0016186.
[22]
Halazonetis, T.D.; Gorgoulis, V.G.; Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319, 1352–1355, doi:10.1126/science.1140735.
[23]
Kallioniemi, A.; Kallioniemi, O.P.; Waldman, F.M.; Chen, L.C.; Yu, L.C.; Fung, Y.K.; Smith, H.S.; Pinkel, D.; Gray, J.W. Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization. Cytogenet. Cell Genet. 1992, 60, 190–193.
[24]
Raj, A.; van den Bogaard, P.; Rifkin, S.A.; van Oudenaarden, A.; Tyagi, S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat. Methods 2008, 5, 877–879.
[25]
S？derberg, O.; Gullberg, M.; Jarvius, M.; Ridderstr？le, K.; Leuchowius, K.J.; Jarvius, J.; Wester, K.; Hydbring, P.; Bahram, F.; Larsson, L.G.; Landegren, U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 2006, 3, 995–1000.
[26]
Leuchowius, K.J.; Jarvius, M.; Wickstr？m, M.; Rickardson, L.; Landegren, U.; Larsson, R.; S？derberg, O.; Frykn？s, M.; Jarvius, J. High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation. Mol. Cell. Proteomics 2010, 9, 178–183, doi:10.1074/mcp.M900331-MCP200.
